Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Merck Ventures B.V. investment portfolio

Merck Ventures B.V. has made numerous investments in companies such as Storm Therapeutics, Enara Bio, and Labgenius within the Biotech sector.

vc
Portfolio
12
Team
0

Portfolio (12)

CompanySectorCitySourceLast confirmed on
Artios Pharma Limited
Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours.
Healthcare & Life SciencesCambridgeConfirmed2025-12-28
Enara Bio Limited
Enara Bio is a biotechnology company that discovers novel “Dark Antigen” cancer targets and develops bispecific T‑cell engager immunotherapies for solid tumours. It collaborates with pharmaceutical partners such as Boehringer Ingelheim to advance these therapies toward clinical trials.
Healthcare & Life SciencesOxfordConfirmed2025-11-07

Sign up to see the full portfolio

+10 more companies

Sign up

Shareholding changes (15)

Merck Ventures B.V.'s positions across portfolio companies
2026
2025

Sign up free to see when this investor has bought or sold shares.

+13 more changes

Sign up

Articles (2)